Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(41 sites)
United States
Arizona Oncology Associates, Tucson, Arizona University of Southern California, Los Angeles, California Hoag Memorial Hospital, Newport Beach, California Rocky Mountain Cancer Centers, Denver, Colorado Yale Cancer Center, New Haven, Connecticut Christiana Care Helen F. Graham Cancer Center, Newark, Delaware John Hopkins Kimmer Cancer Center, Washington D.C., District of Columbia Florida Cancer Specialists, Daytona Beach, Florida Florida Cancer Specialists, Fleming Island, Florida Ocala Oncology Center, Ocala, Florida AdventHealth Research Institute, Orlando, Florida Illinois Cancer Specialists, Arlington Heights, Illinois University of Illinois, Chicago, Illinois Indiana University, Indianapolis, Indiana Norton Cancer Institute, Louisville, Kentucky American Oncology Partners, P.A. - The Center for Cancer & Blood Disorders, Bethesda, Maryland Maryland Oncology Hematology, Silver Spring, Maryland Dana-Farber Cancer Institute, Boston, Massachusetts START Midwest, Grand Rapids, Michigan Regions Hospital Cancer Care Center, Saint Paul, Minnesota Washington University in St Louis, St Louis, Missouri Nebraska Cancer Center Oncology Hematology West P.C., Omaha, Nebraska Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey Icahn School of Medicine at Mount Sinai, New York, New York Stony Brook University, Stony Brook, New York University of Cincinnati, Cincinnati, Ohio Zangmeister Cancer Center, Columbus, Ohio The University of Toledo, Toledo, Ohio University of Oklahoma, Oklahoma City, Oklahoma University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania Medical University of South Carolina, Charleston, South Carolina Sarah Cannon Research Institute, Nashville, Tennessee Vanderbilt - Ingram Cancer Center, Nashville, Tennessee Texas Oncology - Dallas, Dallas, Texas START Dallas, Fort Worth, Texas The University of Texas MD Anderson Cancer Center, Houston, Texas Texas Oncology - Paris, Paris, Texas NEXT Oncology, San Antonio, Texas NEXT Oncology Virginia, Fairfax, Virginia Northwest Medical Specialties, Tacoma, Washington Northwest Cancer Specialists, Vancouver, Washington